T. Clay
AuthID: R-00G-DWQ
1
TÃTULO: CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting Full Text
AUTORES: Norell, H; Zhang, Y; McCracken, J; Martins Da Palma, T; Lesher, A; Liu, Y; Roszkowski, JJ; Temple, A; Callender, GG; Clay, T; Orentas, R; Guevara Patino, J; Nishimura, MI;
PUBLICAÇÃO: 2010, FONTE: Cancer Immunology, Immunotherapy, VOLUME: 59, NÚMERO: 6
AUTORES: Norell, H; Zhang, Y; McCracken, J; Martins Da Palma, T; Lesher, A; Liu, Y; Roszkowski, JJ; Temple, A; Callender, GG; Clay, T; Orentas, R; Guevara Patino, J; Nishimura, MI;
PUBLICAÇÃO: 2010, FONTE: Cancer Immunology, Immunotherapy, VOLUME: 59, NÚMERO: 6
INDEXADO EM: 
Scopus 
CrossRef
Scopus CrossRef